Second quarter 2026 results were impacted by lower elective procedure volumes, unfavorable payer mix, and higher uncompensated care, despite operational improvements and cost controls. Guidance for the year was revised downward, reflecting ongoing macroeconomic headwinds and payer challenges.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.